Dexamethasone suppresses interleukin-22 associated with bacterial infection in vitro and in vivo

Clinical and Experimental Immunology

Volumn 157, Issue 3, 2009, Pages 370-376

  Ziesche E ^a   Scheiermann, P ^a   Bachmann, M ^a   Sadik, C D ^a   Hofstetter, C ^a   Zwissler, B ^b   Pfeilschifter, J ^a   Muhl H ^a,b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Glucocorticoids; Inflammation; Interleukin 22; Sepsis

Indexed keywords

CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 22; INTERLEUKIN 8; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INNATE IMMUNITY; INTESTINE; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; STAPHYLOCOCCUS EPIDERMIDIS;

ANIMALS; CASE-CONTROL STUDIES; CELLS, CULTURED; DEPRESSION, CHEMICAL; DEXAMETHASONE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; INTERLEUKINS; MALE; MODELS, ANIMAL; PERITONITIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 67651204889     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03969.x     Document Type: Article

References (33)

1. Wolk K, Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 2006 17 : 367 80.
2. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007 13 : 139 45.
3. Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007 8 : 950 7.
4. Gu Y, Yang J, Ouyang X et al. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 2008 38 : 1807 13.
5. Heinrich PC, Behrmann I, Haan S et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003 374 : 1 20.
6. Andoh A, Zhang Z, Inatomi O et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005 129 : 969 84.
7. Brand S, Dambacher J, Beigel F et al. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am J Physiol Gastrointest Liver Physiol 2007 292 : G1019 28.
8. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007 7 : 454 65.
9. Radaeva S, Sun R, Pan HN, Hong F, Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004 39 : 1332 42.
10. Zenewicz LA, Yancopoulos GD, Valenzuela DM et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007 27 : 647 59.
11. Sugimoto K, Ogawa A, Mizoguchi E et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008 118 : 534 44.
12. Zenewicz LA, Yancopoulos GD, Valenzuela DM et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008 29 : 947 57.
13. Ma HL, Liang S, Li J et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 2008 118 : 597 607.
14. Brand S, Beigel F, Olszak T et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006 290 : G827 38.
15. Zheng Y, Valdez PA, Danilenko DM et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008 14 : 282 9.
16. Aujla SJ, Chan YR, Zheng M et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008 14 : 275 81.
17. Chakravortty D, Hensel M. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect 2003 5 : 621 7.
18. Ziesché E, Bachmann M, Kleinert H, Pfeilschifter J, Mühl H. The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J Biol Chem 2007 282 : 16006 15.
19. Satoh S, Oishi K, Iwagaki A et al. Dexamethasone impairs pulmonary defence against Pseudomonas aeruginosa through suppressing iNOS gene expression and peroxynitrite production in mice. Clin Exp Immunol 2001 126 : 266 73.
20. Kebir H, Kreymborg K, Ifergan I et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007 13 : 1173 5.
21. Madara JL. Warner-Lambert/Parke-Davis Award lecture. Pathobiology of the intestinal epithelial barrier. Am J Pathol 1990 137 : 1273 81.
22. Agrawal A, Durrani S, Leiper K et al. Effect of systemic corticosteroid therapy on risk for intra-abdominal or pelvic abscess in non-operated Crohn's disease. Clin Gastroenterol Hepatol 2005 3 : 1215 20.
23. Aberra FN, Lewis JD, Hass D et al. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 2003 125 : 320 7.
24. Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum 2000 43 : 1141 5.
25. Scheiermann P, Hoegl S, Revermann M et al. Cecal ligation and incision: an acute onset model of severe sepsis in rats. J Surg Res 2009 151 : 132 7.
26. Wolk K, Witte E, Wallace E et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006 36 : 1309 23.
27. Franchimont D, Martens H, Hagelstein MT et al. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 1999 84 : 2834 9.
28. Weber GF, Schlautkötter S, Kaiser-Moore S et al. Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis. Infect Immun 2007 75 : 1690 7.
29. Riedemann NC, Guo RF, Bernacki KD et al. Regulation by C5a of neutrophil activation during sepsis. Immunity 2003 19 : 193 202.
30. Guo RF, Riedemann NC, Sun L et al. Divergent signaling pathways in phagocytic cells during sepsis. J Immunol 2006 177 : 1306 13.
31. Singleton KD, Beckey VE, Wischmeyer PE. Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 2005 24 : 583 9.
32. McKinley L, Alcorn JF, Peterson A et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008 181 : 4089 97.
33. Gatt M, Reddy S, Macfie J. Review article: bacterial translocation in the critically ill - evidence and methods of prevention. Aliment Pharmacol Ther 2007 25 : 741 57.